These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 22612509)
1. Ubiquitin-related proteins in neuronal and glial intranuclear inclusions in intranuclear inclusion body disease. Mori F; Tanji K; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Kamitani T; Yoshida M; Wakabayashi K Pathol Int; 2012 Jun; 62(6):407-11. PubMed ID: 22612509 [TBL] [Abstract][Full Text] [Related]
2. FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease. Mori F; Tanji K; Kon T; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Yoshida M; Wakabayashi K Neuropathol Appl Neurobiol; 2012 Jun; 38(4):322-8. PubMed ID: 21883376 [TBL] [Abstract][Full Text] [Related]
3. Incipient intranuclear inclusion body disease in a 78-year-old woman. Mori F; Miki Y; Tanji K; Ogura E; Yagihashi N; Jensen PH; Wakabayashi K Neuropathology; 2011 Apr; 31(2):188-93. PubMed ID: 20667015 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of Marinesco bodies, using antibodies against proteins implicated in the ubiquitin-proteasome system, autophagy and aggresome formation. Odagiri S; Tanji K; Mori F; Kakita A; Takahashi H; Kamitani T; Wakabayashi K Neuropathology; 2012 Jun; 32(3):261-6. PubMed ID: 22118216 [TBL] [Abstract][Full Text] [Related]
5. NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture. Pountney DL; Raftery MJ; Chegini F; Blumbergs PC; Gai WP Acta Neuropathol; 2008 Dec; 116(6):603-14. PubMed ID: 18836734 [TBL] [Abstract][Full Text] [Related]
6. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders. Mori F; Nishie M; Piao YS; Kito K; Kamitani T; Takahashi H; Wakabayashi K Neuropathol Appl Neurobiol; 2005 Feb; 31(1):53-61. PubMed ID: 15634231 [TBL] [Abstract][Full Text] [Related]
7. Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease. Sone J; Tanaka F; Koike H; Inukai A; Katsuno M; Yoshida M; Watanabe H; Sobue G Neurology; 2011 Apr; 76(16):1372-6. PubMed ID: 21411744 [TBL] [Abstract][Full Text] [Related]
8. Inclusion-positive cell types in adult-onset intranuclear inclusion body disease: implications for clinical diagnosis. Liu Y; Mimuro M; Yoshida M; Hashizume Y; Niwa H; Miyao S; Ujihira N; Akatsu H Acta Neuropathol; 2008 Dec; 116(6):615-23. PubMed ID: 18923837 [TBL] [Abstract][Full Text] [Related]
9. Valosin-containing protein immunoreactivity in tauopathies, synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease. Mori F; Tanji K; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K Neuropathology; 2013 Dec; 33(6):637-44. PubMed ID: 23782134 [TBL] [Abstract][Full Text] [Related]
10. Neuronal intranuclear inclusion disease in a horse. Pumarola M; Vidal E; Trens JM; SerafĂn A; Marquez M; Ferrer I Acta Neuropathol; 2005 Aug; 110(2):191-5. PubMed ID: 15971054 [TBL] [Abstract][Full Text] [Related]
11. Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child. McFadden K; Hamilton RL; Insalaco SJ; Lavine L; Al-Mateen M; Wang G; Wiley CA J Neuropathol Exp Neurol; 2005 Jun; 64(6):545-52. PubMed ID: 15977647 [TBL] [Abstract][Full Text] [Related]
12. SUMO on the road to neurodegeneration. Dorval V; Fraser PE Biochim Biophys Acta; 2007 Jun; 1773(6):694-706. PubMed ID: 17475350 [TBL] [Abstract][Full Text] [Related]
13. The PML-nuclear inclusion of human supraoptic neurons: a new compartment with SUMO-1- and ubiquitin-proteasome-associated domains. Villagra NT; Navascues J; Casafont I; Val-Bernal JF; Lafarga M; Berciano MT Neurobiol Dis; 2006 Jan; 21(1):181-93. PubMed ID: 16125395 [TBL] [Abstract][Full Text] [Related]
14. Autophagy-related proteins (p62, NBR1 and LC3) in intranuclear inclusions in neurodegenerative diseases. Mori F; Tanji K; Odagiri S; Toyoshima Y; Yoshida M; Kakita A; Takahashi H; Wakabayashi K Neurosci Lett; 2012 Aug; 522(2):134-8. PubMed ID: 22728060 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localization of exoribonucleases (DIS3L2 and XRN1) in intranuclear inclusion body disease. Mori F; Tanji K; Miki Y; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K Neurosci Lett; 2018 Jan; 662():389-394. PubMed ID: 29100804 [TBL] [Abstract][Full Text] [Related]
17. G protein-coupled receptor 26 immunoreactivity in intranuclear inclusions associated with polyglutamine and intranuclear inclusion body diseases. Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Kakita A; Takahashi H; Utsumi J; Sasaki H; Wakabayashi K Neuropathology; 2016 Feb; 36(1):50-5. PubMed ID: 26303144 [TBL] [Abstract][Full Text] [Related]
18. Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases. Miki Y; Mori F; Kon T; Tanji K; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K Neuropathology; 2014 Apr; 34(2):148-58. PubMed ID: 24313828 [TBL] [Abstract][Full Text] [Related]
19. Neuronal intranuclear hyaline inclusion disease showing motor-sensory and autonomic neuropathy. Sone J; Hishikawa N; Koike H; Hattori N; Hirayama M; Nagamatsu M; Yamamoto M; Tanaka F; Yoshida M; Hashizume Y; Imamura H; Yamada E; Sobue G Neurology; 2005 Nov; 65(10):1538-43. PubMed ID: 16301479 [TBL] [Abstract][Full Text] [Related]
20. Hereditary dentatorubral-pallidoluysian atrophy: detection of widespread ubiquitinated neuronal and glial intranuclear inclusions in the brain. Hayashi Y; Kakita A; Yamada M; Koide R; Igarashi S; Takano H; Ikeuchi T; Wakabayashi K; Egawa S; Tsuji S; Takahashi H Acta Neuropathol; 1998 Dec; 96(6):547-52. PubMed ID: 9845282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]